Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019
October 31 2019 - 4:01PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) a physician-led
biopharmaceutical company focused on immuno-inflammatory diseases,
today announced it will report financial results for the third
quarter 2019, Thursday, November 7th, after U.S. financial markets
close.
Management will conduct a conference call at 5:00 PM ET to
discuss Aclaris’ financial results and provide a general business
update. The conference call will be webcast live over the Internet
and can be accessed by logging on to the “Investors” page of the
Aclaris Therapeutics website, www.aclaristx.com, prior to the
event. A replay of the webcast will be archived on the Aclaris
Therapeutics website for 30 days following the call.
To participate on the live call, please dial (844)
776-7782 (domestic) or (661) 378-9535 (international), and
reference conference ID 2698128 prior to the start of the
call.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a physician-led biopharmaceutical company
committed to addressing the needs of patients with
immuno-inflammatory diseases who lack satisfactory treatment
options. The company’s diverse and multi-stage portfolio includes
one late-stage investigational drug candidate and a pipeline
powered by a robust R&D engine exploring protein kinase
regulation. For additional information, please visit
www.aclaristx.com and follow Aclaris on LinkedIn or Twitter
@aclaristx.
Aclaris ContactMichael Tung, M.D.Corporate Strategy/Investor
Relations484-329-2140mtung@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024